629 related articles for article (PubMed ID: 30604628)
21. Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis.
Kass DJ; Nouraie M; Glassberg MK; Ramreddy N; Fernandez K; Harlow L; Zhang Y; Chen J; Kerr GS; Reimold AM; England BR; Mikuls TR; Gibson KF; Dellaripa PF; Rosas IO; Oddis CV; Ascherman DP
Arthritis Rheumatol; 2020 Mar; 72(3):409-419. PubMed ID: 31532072
[TBL] [Abstract][Full Text] [Related]
22. Genetic association between interleukin-17 and susceptibility to rheumatoid arthritis.
Zhao R; Zhang YW; Yao JY; Qiao J; Song S; Zhang SX; Wang CH; Li XF
BMC Med Genomics; 2023 Nov; 16(1):277. PubMed ID: 37926850
[TBL] [Abstract][Full Text] [Related]
23. Survival differences in rheumatoid arthritis interstitial lung disease and idiopathic pulmonary fibrosis may be explained by delays in presentation: results from multivariate analysis in a monocentric UK study.
Dubey S; Woodhead F
Rheumatol Int; 2024 Jan; 44(1):99-105. PubMed ID: 38085367
[TBL] [Abstract][Full Text] [Related]
24. Noncanonical JAK1/STAT3 interactions with TGF-β modulate myofibroblast transdifferentiation and fibrosis.
Wang F; Wang S; Zhang C; Tian X; Zhou Y; Xuan W; Matteson EL; Luo F; Tschumperlin D; Vassallo R
Am J Physiol Lung Cell Mol Physiol; 2022 Dec; 323(6):L698-L714. PubMed ID: 36283961
[TBL] [Abstract][Full Text] [Related]
25. Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease.
Lescoat A; Lelong M; Jeljeli M; Piquet-Pellorce C; Morzadec C; Ballerie A; Jouneau S; Jego P; Vernhet L; Batteux F; Fardel O; Lecureur V
Biochem Pharmacol; 2020 Aug; 178():114103. PubMed ID: 32562787
[TBL] [Abstract][Full Text] [Related]
26. PD-1 up-regulation on CD4
Celada LJ; Kropski JA; Herazo-Maya JD; Luo W; Creecy A; Abad AT; Chioma OS; Lee G; Hassell NE; Shaginurova GI; Wang Y; Johnson JE; Kerrigan A; Mason WR; Baughman RP; Ayers GD; Bernard GR; Culver DA; Montgomery CG; Maher TM; Molyneaux PL; Noth I; Mutsaers SE; Prele CM; Peebles RS; Newcomb DC; Kaminski N; Blackwell TS; Van Kaer L; Drake WP
Sci Transl Med; 2018 Sep; 10(460):. PubMed ID: 30257954
[TBL] [Abstract][Full Text] [Related]
27. IL-17A/IL-17RA promotes invasion and activates MMP-2 and MMP-9 expression via p38 MAPK signaling pathway in non-small cell lung cancer.
Wu Z; He D; Zhao S; Wang H
Mol Cell Biochem; 2019 May; 455(1-2):195-206. PubMed ID: 30564960
[TBL] [Abstract][Full Text] [Related]
28. Expansion of distinct peripheral blood myeloid cell subpopulations in patients with rheumatoid arthritis-associated interstitial lung disease.
Poole JA; Cole KE; Thiele GM; Talmadge JE; England BR; Nelson AJ; Gleason A; Schwab A; Gaurav R; Duryee MJ; Bailey KL; Romberger DJ; Hershberger D; De Graaff JV; May SM; Walenz R; Kramer B; Mikuls TR
Int Immunopharmacol; 2024 Jan; 127():111330. PubMed ID: 38086271
[TBL] [Abstract][Full Text] [Related]
29. Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases.
Wollin L; Distler JHW; Redente EF; Riches DWH; Stowasser S; Schlenker-Herceg R; Maher TM; Kolb M
Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31285305
[TBL] [Abstract][Full Text] [Related]
30. The Lung in Rheumatoid Arthritis: Focus on Interstitial Lung Disease.
Spagnolo P; Lee JS; Sverzellati N; Rossi G; Cottin V
Arthritis Rheumatol; 2018 Oct; 70(10):1544-1554. PubMed ID: 29806092
[TBL] [Abstract][Full Text] [Related]
31. The JAK2 pathway is activated in idiopathic pulmonary fibrosis.
Milara J; Hernandez G; Ballester B; Morell A; Roger I; Montero P; Escrivá J; Lloris JM; Molina-Molina M; Morcillo E; Cortijo J
Respir Res; 2018 Feb; 19(1):24. PubMed ID: 29409529
[TBL] [Abstract][Full Text] [Related]
32. Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis.
Ghebremariam YT; Cooke JP; Gerhart W; Griego C; Brower JB; Doyle-Eisele M; Moeller BC; Zhou Q; Ho L; de Andrade J; Raghu G; Peterson L; Rivera A; Rosen GD
J Transl Med; 2015 Aug; 13():249. PubMed ID: 26231702
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of NF-κB by ACT001 reduces fibroblast activity in idiopathic pulmonary fibrosis.
Jaffar J; Glaspole I; Symons K; Westall G
Biomed Pharmacother; 2021 Jun; 138():111471. PubMed ID: 33730605
[TBL] [Abstract][Full Text] [Related]
34. Hsp90 regulation of fibroblast activation in pulmonary fibrosis.
Sontake V; Wang Y; Kasam RK; Sinner D; Reddy GB; Naren AP; McCormack FX; White ES; Jegga AG; Madala SK
JCI Insight; 2017 Feb; 2(4):e91454. PubMed ID: 28239659
[TBL] [Abstract][Full Text] [Related]
35. Pathological Insight into 5-HT
Löfdahl A; Tornling G; Wigén J; Larsson-Callerfelt AK; Wenglén C; Westergren-Thorsson G
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379351
[TBL] [Abstract][Full Text] [Related]
36. Combination treatment with Janus kinase inhibitor and nintedanib for rheumatoid arthritis with progressive interstitial lung disease: A case report.
Mochizuki T; Yano K; Ikari K; Okazaki K
Mod Rheumatol Case Rep; 2023 Jun; 7(2):350-353. PubMed ID: 37061836
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol attenuates inflammation and fibrosis in rheumatoid arthritis-associated interstitial lung disease via the AKT/TMEM175 pathway.
Liu N; Fan X; Shao Y; Chen S; Wang T; Yao T; Chen X
J Transl Med; 2024 May; 22(1):457. PubMed ID: 38745204
[TBL] [Abstract][Full Text] [Related]
38. Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells.
Huang F; Kao CY; Wachi S; Thai P; Ryu J; Wu R
J Immunol; 2007 Nov; 179(10):6504-13. PubMed ID: 17982039
[TBL] [Abstract][Full Text] [Related]
39. Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases.
Pulito-Cueto V; Genre F; López-Mejías R; Mora-Cuesta VM; Iturbe-Fernández D; Portilla V; Sebastián Mora-Gil M; Ocejo-Vinyals JG; Gualillo O; Blanco R; Corrales A; Ferraz-Amaro I; Castañeda S; Cifrián Martínez JM; Atienza-Mateo B; Remuzgo-Martínez S; González-Gay MÁ
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674789
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-17A promotes rheumatoid arthritis synoviocytes migration and invasion under hypoxia by increasing MMP2 and MMP9 expression through NF-κB/HIF-1α pathway.
Li G; Zhang Y; Qian Y; Zhang H; Guo S; Sunagawa M; Hisamitsu T; Liu Y
Mol Immunol; 2013 Mar; 53(3):227-36. PubMed ID: 22960198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
